Position in GRFS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,564,590
-$883,940 QoQ
Shares Held
1,068,445
+1.4% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 164 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $19,103,501,096 across 19 Drug Manufacturers - General names. GRFS ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,646,119 | $5,572,694,974 | |
| 2 | JNJ |
Johnson & Johnson
|
17,374,433 | $4,412,584,747 | |
| 3 | AMGN |
Amgen Inc
|
7,235,462 | $2,620,105,497 | |
| 4 | ABBV |
AbbVie Inc.
|
9,017,580 | $2,269,183,828 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,658,434 | $1,498,108,767 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
6,439,586 | $813,577,293 | |
| 7 | PFE |
Pfizer Inc
|
20,193,675 | $486,263,691 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,321,643 | $364,253,067 |
All Filings in GRFS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,564,590 | 1,068,445 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,448,530 | 1,053,433 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $8,987,134 | 961,191 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,684,003 | 871,888 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,393,155 | 817,827 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,462,690 | 768,311 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,653,369 | 625,453 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,153,830 | 692,999 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,593,149 | 727,916 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,619,336 | 541,817 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $5,970,080 | 516,443 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $4,236,827 | 463,548 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,315,787 | 471,156 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $3,446,380 | 467,623 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,464,786 | 407,622 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,804,049 | 455,203 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,549,135 | 467,099 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,295,349 | 453,369 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,653,837 | 325,364 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,743,252 | 324,658 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,192,595 | 356,922 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,674,352 | 328,187 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $5,178,910 | 280,852 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $3,383,682 | 195,025 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $3,761,105 | 206,201 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,908,870 | 194,085 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||